A Phase 1/1b Open-Label Dose Escalation and Expansion Study of Bcl-2 Inhibitor BGB-11417 in Patients with Mature B- Cell Malignancies.

  • Si Lun Tam, Con (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date27/05/22 → 31/12/26

Keywords

  • Malignant Haematology
  • B-cell Malignancies
  • Clinical trial